We’ll help you find the highest quality medicine that you need.
is indicated for the treatment of:
1) Refractory complex partial seizures as adjunctive therapy in patients ≥10 years of age who have responded inadequately to several alternative treatments
2) Infantile spasms–monotherapy in infants 1 month to 2 years of age for whom the potential benefits outweigh the potential risk of vision loss.
Manufactured by: Lundbeck Pharms, LLC
Active Ingredient(s): Vigabatrin
Dosage Form: Solution, oral
Strength: 500 mg/packet
FDA approved: August 21, 2009
More information about Sabril:
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020427s016,022006s018lbl.pdf
https://www.lundbeck.com/upload/us/files/pdf/Products/Sabril_PI_US_EN.pdf
is indicated for the treatment of patients with Wilson’s disease who are intolerant of Penicillamine.
Manufactured by: Valeant Pharmaceuticals North America, LLC
Active Ingredient(s): Trientine Hydrochloride
Dosage Form: Capsule, oral
Strength: 250 mg
FDA approved: November 8, 1985
More information about Syprine:
is indicatedfor the treatment of renal cell carcinoma (RCC) and Imatinib-resistant gastrointestinal stromal tumor.
Manufactured by: Pfizer, Inc.
Active Ingredient(s): Sunitinib Malate
Dosage Form: Capsules, oral
Strength: 12.5 mg, 50 mg
FDA approved: May 20, 2011(First approval26th January, 2006)
More information about Sutent:
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021968lbl.pdf
is indicated for the treatment of chronic hepatitis C (CHC) infection as a component of a combination antiviral treatment regimen. Sovaldi efficacy has been established in subjects with HCV genotype 1, 2, 3 or 4 infection, including those with hepatocellular carcinoma meeting Milan criteria (awaiting liver transplantation) and those with HCV/HIV-1 co-infection.
Manufactured by: Gilead Sciences, Inc
Active Ingredient(s): Sofosbuvir
Dosage Form: Tablet, oral
Strength: 400 mg
FDA approved: December 6, 2013
More information about Sovaldi:
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204671s000lbl.pdf
http://www.gilead.com/~/media/Files/pdfs/medicines/liver-disease/sovaldi/sovaldi_pi.pdf